2008
DOI: 10.1016/j.thromres.2007.06.003
|View full text |Cite
|
Sign up to set email alerts
|

The role of fibrinogen and fibrinolysis in peripheral arterial disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
43
0
3

Year Published

2009
2009
2018
2018

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 50 publications
(49 citation statements)
references
References 125 publications
3
43
0
3
Order By: Relevance
“…However, there is a paucity of information about the impact of smoking cessation on fibrin clot properties. A few studies refer to the influence of current smoking rather than on smoking cessation [3,5,7]. To assess fibrin clot structure and function, we adopted the method of fibrin clot formation from citrated plasma.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, there is a paucity of information about the impact of smoking cessation on fibrin clot properties. A few studies refer to the influence of current smoking rather than on smoking cessation [3,5,7]. To assess fibrin clot structure and function, we adopted the method of fibrin clot formation from citrated plasma.…”
Section: Discussionmentioning
confidence: 99%
“…The benefits of smoking cessation are not dependent on age, sex and hypertensions, although the decrease in the risk appears to be dependent on the duration of smoking abstinence and the number of cigarettes smoked per day [3]. Cigarette smoking is the strongest, dose-dependent environmental factor, determining plasma fibrinogen concentration, plasma clot permeability and susceptibility to lysis [4,5].…”
Section: Introductionmentioning
confidence: 99%
“…Meanwhile, BMI, eGFR and the serum levels of albumin, total cholesterol, RLP cholesterol and triglycerides were higher in the patients treated with statins, whereas the serum levels of homocysteine, D-dimer, TAT and PIC were lower in these patients. The prevalence of aspirin, clopido- high-sensitivity C-reactive protein, Total-C: total cholesterol, LDL-C: low-density lipoprotein cholesterol, HDL-C: high-density lipoprotein cholesterol, RLP-C: remnant-like particle cholesterol, TAT: thrombin-antithrombin complex, PIC: plasmin-2 plasmin inhibitor complex, BNP: brain natriuretic peptide, ACE: angiotensin-converting enzyme, ARB: angiotensin receptor blocker tion, the fibrinogen level is particularly associated with the severity and potential for the further development of PAD 26) and functions as an independent risk factor for CAD 25) . Hyperhomocysteinemia is an independent risk factor for atherosclerosis and a stronger risk factor for PAD than for CAD 16,17) , with an association with death or severe vascular events in patients with PAD 27) .…”
Section: Discussionmentioning
confidence: 99%
“…Several studies have reported low t-PA and, more frequently, high PAI-1 values in PAD patients [172]. Impaired fibrinolysis appears to play a role in the future development of PAD in patients with type 2 DM [173].…”
Section: Tissue Plasminogen Activator (Tpa) Plasminogen Activator Inmentioning
confidence: 99%